ATE102191T1 - SUBSTITUTED 4-(1H-IMIDAZOLE-1-YL>BENZAMIDES AS ANTIARHYTHMIC AGENTS. - Google Patents

SUBSTITUTED 4-(1H-IMIDAZOLE-1-YL>BENZAMIDES AS ANTIARHYTHMIC AGENTS.

Info

Publication number
ATE102191T1
ATE102191T1 AT88730104T AT88730104T ATE102191T1 AT E102191 T1 ATE102191 T1 AT E102191T1 AT 88730104 T AT88730104 T AT 88730104T AT 88730104 T AT88730104 T AT 88730104T AT E102191 T1 ATE102191 T1 AT E102191T1
Authority
AT
Austria
Prior art keywords
benzamides
agents
substituted
antiarhythmic
imidazole
Prior art date
Application number
AT88730104T
Other languages
German (de)
Inventor
Klaus Nickisch
Randall Edward Lis
William Carl Lumma Jr
Thomas Kenneth Morgan Jr
Ronald Andre Wohl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of ATE102191T1 publication Critical patent/ATE102191T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Novel substituted 4-[1H-imidazol-1-yl]benzamides and their use in the treatment of cardiac arrhythmias especially as Class III or combination Class I/III antiarrhythmic agents is described. Pharmaceutical formulations containing such compounds are also disclosed.
AT88730104T 1987-05-05 1988-05-02 SUBSTITUTED 4-(1H-IMIDAZOLE-1-YL>BENZAMIDES AS ANTIARHYTHMIC AGENTS. ATE102191T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/046,222 US4804662A (en) 1987-05-05 1987-05-05 Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents
EP88730104A EP0290377B1 (en) 1987-05-05 1988-05-02 Substituted 4-[1H-Imidazol-1-yl] benzamides as antiarrhythmic agents

Publications (1)

Publication Number Publication Date
ATE102191T1 true ATE102191T1 (en) 1994-03-15

Family

ID=21942261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88730104T ATE102191T1 (en) 1987-05-05 1988-05-02 SUBSTITUTED 4-(1H-IMIDAZOLE-1-YL>BENZAMIDES AS ANTIARHYTHMIC AGENTS.

Country Status (5)

Country Link
US (1) US4804662A (en)
EP (1) EP0290377B1 (en)
AT (1) ATE102191T1 (en)
DE (1) DE3888012T2 (en)
ES (1) ES2051885T3 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051423A (en) * 1988-07-13 1991-09-24 Schering Ag Derivatized alkanolamines as cardiovascular agents
FR2642972B1 (en) * 1989-02-14 1994-08-05 Inst Nat Sante Rech Med AGENTS FOR THE DIAGNOSIS AND TREATMENT OF MELANOMAS, HALOGENATED AROMATIC DERIVATIVES SUITABLE FOR USE AS SUCH AGENTS AND THEIR PREPARATION
US5112824A (en) * 1989-12-08 1992-05-12 Merck & Co., Inc. Benzofuran compounds as class III antiarrhythmic agents
US5215989A (en) * 1989-12-08 1993-06-01 Merck & Co., Inc. Nitrogen-containing heterocyclic compounds as class III antiarrhythmic agents
US5032598A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Nitrogens containing heterocyclic compounds as class III antiarrhythmic agents
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
AU7997091A (en) * 1990-05-30 1991-12-31 American Home Products Corporation Substituted arylsulfonamides and benzamides
US5189036A (en) * 1990-06-20 1993-02-23 Schering Ag Imidazolylbenzoyl substituted heterocycles
CA2115427C (en) * 1991-08-14 2000-05-02 Stanford Salvatore Pelosi Jr. Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
US5183813A (en) * 1992-02-19 1993-02-02 Sterling Winthrop Inc. Antiarrhythmic agents
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
US5795893A (en) * 1994-12-22 1998-08-18 Smithkline Beecham Corporation Fibrinogen receptor antagonists
SK18097A3 (en) * 1996-02-28 1997-10-08 American Cyanamid Co Substituted omega £phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl| £alkyl, alkenyl or alkinyl|amino carboxamides, sulfonamides and phosphonyl amides, pharmaceutical preparation containing them, process for producing them and their use
WO1998037068A1 (en) 1997-02-21 1998-08-27 Bristol-Myers Squibb Company Benzoic acid derivatives and related compounds as antiarrhythmic agents
WO2008057543A2 (en) * 2006-11-06 2008-05-15 Acadia Pharmaceuticals Inc. Uii-modulating compounds and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508718A (en) * 1984-01-16 1985-04-02 Warner-Lambert Company Cardiotonic and antihypertensive oxadiazinone compounds

Also Published As

Publication number Publication date
US4804662A (en) 1989-02-14
DE3888012T2 (en) 1994-10-13
EP0290377A1 (en) 1988-11-09
ES2051885T3 (en) 1994-07-01
DE3888012D1 (en) 1994-04-14
EP0290377B1 (en) 1994-03-02

Similar Documents

Publication Publication Date Title
ATE102191T1 (en) SUBSTITUTED 4-(1H-IMIDAZOLE-1-YL>BENZAMIDES AS ANTIARHYTHMIC AGENTS.
SE9604786D0 (en) New compounds
DE3562238D1 (en) Substituted sulfonamidobenzamides, antiarrythmic agents and compositions thereof
SE8804036L (en) NEW USE OF 11,28-DIOXA-4-AZATRICKLO (22.3.1.04.9) -OCTAKOS-18-EN-DERIVATIVE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DK320587A (en) NEW PHARMACOLOGICAL RELATIONS
BR9813668A (en) Compound, use of the same, process to prepare it, pharmaceutical formulation, and, prophylaxis or treatment of an arrhythmia
HUT51139A (en) Process for production of medical compositions containing as active substance derivatives of 4-substituated imidasole
NZ208831A (en) Imidazolium derivatives and pharmaceutical compositions
DK0409435T3 (en) Heteroberl piperazines as antipsychotics
PT84007B (en) {{4- {4- (4-PHENYL-1-PYERAZINYL) PHENOXYMETHYL} -1,3-DIOXOLAN-2-YL} METHYL} -1H-IMIDAZOES AND 1H-1,2,3,4- 4-TRIAZOIS AND ANTI-FUNGICIDES AND ANTI-BACTERYCIDES COMPOUNDS THAT CONTAIN THEM
FR2636948A1 (en) N- (2-PIPERIDYLMETHYL) SUBSTITUTED ANTIARRHYTHMIC BENZAMIDES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
ES2075845T3 (en) 3,5-DI-TERC-BUTIL-4-HIDROXIFENIL-1,3,4-TIADIAZOLES, OXADIAZOLES AND 3,5-DI-TERC-BUTIL-4-HIDROXIFENIL-1,2,4-TIADIAZOLES, OXADIAZOLES AND TRIAZOLES AS ANTI-INFLAMMATORY AGENTS.
EP0424525A4 (en) NEW AMINES AND THEIR USE.
SE8404065D0 (en) NOVEL BIOLOGICALLY ACTIVE COMPOUNDS
DE3785046A1 (en)
ATE173476T1 (en) 1-(4-(IMIDAZOLE-1-YL)BENZOYL>PIPERIDINE DERIVATIVES AS ANTIARRHYTHMICS
ATE203021T1 (en) USE OF LACTAM COMPOUNDS AS PHARMACEUTICAL ACTIVE INGREDIENTS
ATE92542T1 (en) AZEOTROPEAN-LIKE COMPOSITIONS OF 1,1DICHLORO-2,2,2-TRIFLUORAETHANE AND 1,1-DOCLORO-1FLUORINE|THANE.
SE8600658D0 (en) NOVEL COMPOSITION OF MATTER
DK192988A (en) DIHYDROPYRIDINAMIDES, THEIR PREPARATION AND USE
EP0410114A3 (en) Use of 4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)-1-(4-fluorophenyl)-butanol in pharmaceutical compositions for the treatment of ischemia in brain
NO162557C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE (PYRROL-1-YL) -PHENYLDIHYDROPYRIDAZINONES.
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
HU913267D0 (en) Process for the production of 1-(3,4-dihydro-2-oxo-1h-kinoline-6-yl)-2-(4-)2-phenyl-ethyl-(piperidine-1-yl)-ethanole and ethanone, and of medical preparations containing them as active agents
FI861329L (en) ANVAENDNING AV 4-(ISOXAZOLYL)-THIAZOLE-2-OXAMINE ACID DERIVATIVES.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee